These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1864284

  • 21. In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.
    Rolston KV, Frisbee-Hume S, LeBlanc B, Streeter H, Ho DH.
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):441-9. PubMed ID: 14522520
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Oct; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

  • 23. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN, Felmingham D, O'Hare MD, Robbins MJ, Perry K, Wall RA, Ridgway GL.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
    [Abstract] [Full Text] [Related]

  • 24. In-vitro activity of temafloxacin for gram-positive pathogens.
    Bille J, Glauser MP.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():9-14. PubMed ID: 1664835
    [Abstract] [Full Text] [Related]

  • 25. A review of the antimicrobial activity of the fluoroquinolones.
    Maple P, Brumfitt W, Hamilton-Miller JM.
    J Chemother; 1990 Oct; 2(5):280-94. PubMed ID: 2128638
    [Abstract] [Full Text] [Related]

  • 26. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
    Bremm KD, Petersen U, Metzger KG, Endermann R.
    Chemotherapy; 1992 Oct; 38(6):376-87. PubMed ID: 1288961
    [Abstract] [Full Text] [Related]

  • 27. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [Abstract] [Full Text] [Related]

  • 28. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.
    Chemotherapy; 1998 Sep; 44(2):85-93. PubMed ID: 9551237
    [Abstract] [Full Text] [Related]

  • 29. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 30. Quinolone activity against anaerobes: microbiological aspects.
    Appelbaum PC.
    Drugs; 1995 May; 49 Suppl 2():76-80. PubMed ID: 8549420
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Gooch G, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
    [Abstract] [Full Text] [Related]

  • 33. The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
    Ridgway GL, Salman H, Robbins MJ, Dencer C, Felmingham D.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():31-4. PubMed ID: 9484871
    [Abstract] [Full Text] [Related]

  • 34. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC, Chang SC, Hsu LY, Hsieh WC, Luh KT.
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [Abstract] [Full Text] [Related]

  • 35. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
    [Abstract] [Full Text] [Related]

  • 36. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M, Kinoshita S, Toyama A, Otsuki M, Nishino T.
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [Abstract] [Full Text] [Related]

  • 37. In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes.
    Biedenbach DJ, Jones RN.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1636-42. PubMed ID: 7492122
    [Abstract] [Full Text] [Related]

  • 38. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV, Ho DH, LeBlanc B, Streeter H, Dvorak T.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [Abstract] [Full Text] [Related]

  • 39. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.
    Fung-Tomc JC, Minassian B, Kolek B, Huczko E, Aleksunes L, Stickle T, Washo T, Gradelski E, Valera L, Bonner DP.
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3351-6. PubMed ID: 11083639
    [Abstract] [Full Text] [Related]

  • 40. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
    Wise R, Brenwald NP, Andrews JM, Boswell F.
    J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.